Evidence map›Paper›PMID 38399241›Full record

ArticlePharmaceutics2024

Controlling the Quality of Nanodrugs According to Their New Property-Radiothermal Emission.

Gleb V Petrov, Daria A Galkina, Alena M Koldina, Tatiana V Grebennikova, Olesya V Eliseeva, Yana Yu Chernoryzh, Varvara V Lebedeva, Anton V Syroeshkin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Gleb V PetrovDepartment of Pharmaceutical and Toxicological Chemistry, Medical Institute, RUDN University, 6 Miklukho-Maklaya Street, 117198 Moscow, Russia.ORCID 0009-0004-1123-7393
Daria A GalkinaDepartment of Pharmaceutical and Toxicological Chemistry, Medical Institute, RUDN University, 6 Miklukho-Maklaya Street, 117198 Moscow, Russia.
Alena M KoldinaDepartment of Pharmaceutical and Toxicological Chemistry, Medical Institute, RUDN University, 6 Miklukho-Maklaya Street, 117198 Moscow, Russia.ORCID 0000-0001-8362-2363
Tatiana V GrebennikovaFederal Government Budgetary Institution "National Research Center for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya" of the Ministry of Health of the Russian Federation, 18 Gamaleya St., 123098 Moscow, Russia.ORCID 0000-0002-6141-9361
Olesya V EliseevaFederal Government Budgetary Institution "National Research Center for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya" of the Ministry of Health of the Russian Federation, 18 Gamaleya St., 123098 Moscow, Russia.
Yana Yu ChernoryzhFederal Government Budgetary Institution "National Research Center for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya" of the Ministry of Health of the Russian Federation, 18 Gamaleya St., 123098 Moscow, Russia.ORCID 0000-0001-9848-8515
Varvara V LebedevaFederal Government Budgetary Institution "National Research Center for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya" of the Ministry of Health of the Russian Federation, 18 Gamaleya St., 123098 Moscow, Russia.ORCID 0000-0002-3088-0403
Anton V SyroeshkinDepartment of Pharmaceutical and Toxicological Chemistry, Medical Institute, RUDN University, 6 Miklukho-Maklaya Street, 117198 Moscow, Russia.
Ministry of Health of the Russian Federation · RUPeoples' Friendship University of Russia · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies have shown that complexly shaped nanoparticles (NPs) have their intrinsic radiothermal emission in the millimeter range. This article presents a method for controlling the quality of nanodrugs-immunobiological preparations (IBPs)-based on the detection of their intrinsic radiothermal emissions. The emissivity of interferon (IFN) medicals, determined without opening the primary package, is as follows (µW/m

Indexed as

interferon-α2binterferon-βinterferon-γnanodrugsnanoparticlesquality controlradiothermal emissionSARS CoV-2virus-like particlesVLP vaccines

Identifiers

PMID38399241
PMCPMC10891502
OpenAlexW4391315215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.